SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 92 filers reported holding SERES THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $33,000 | -13.2% | 9,600 | 0.0% | 0.00% | – |
| Q3 2019 | $38,000 | +26.7% | 9,600 | +3.2% | 0.00% | – |
| Q2 2019 | $30,000 | -53.1% | 9,300 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $64,000 | +48.8% | 9,300 | -2.9% | 0.00% | – |
| Q4 2018 | $43,000 | -40.3% | 9,575 | +0.8% | 0.00% | -100.0% |
| Q3 2018 | $72,000 | -1.4% | 9,500 | +11.8% | 0.00% | 0.0% |
| Q2 2018 | $73,000 | +40.4% | 8,500 | +19.7% | 0.00% | 0.0% |
| Q1 2018 | $52,000 | -31.6% | 7,100 | -5.2% | 0.00% | 0.0% |
| Q4 2017 | $76,000 | -38.7% | 7,486 | -2.8% | 0.00% | -50.0% |
| Q3 2017 | $124,000 | -22.5% | 7,700 | -45.2% | 0.00% | -33.3% |
| Q2 2017 | $160,000 | +102.5% | 14,050 | +100.7% | 0.00% | +50.0% |
| Q1 2017 | $79,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |